tetraphase pharmaceuticals i
(TTPH:Consolidated Issue Listed on NASDAQ Global Select )
David Livermore Ph.D.
Member of Clinical Advisory Board, Tetraphase Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 36 board members in 3 different organizations across 3 different industries.|
See Board Relationships
Dr. David M. Livermore, Ph.D. is the Director of the United Kingdom’s Government Health Protection Agency's Antibiotic Resistance Monitoring and Reference Laboratory (ARMRL), where Dr. Livermore has responsibility for investigating bacteria with unusual resistance phenotypes and assessing their mechanisms and public health importance. He serves as a Member of Scientific Advisory Board at Calixa Therapeutics, Inc. He serves as a Clinical Advisory Board at Tetraphase Pharmaceuticals, ...
480 Arsenal StreetPhone: 617-715-3600
Watertown, Massachusetts 02472
Board Members Memberships*There is no Board Members Memberships data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|